SUPREP Bowel Prep (Braintree Laboratories, Inc.)
Welcome to the PulseAid listing for the SUPREP Bowel Prep drug offered from Braintree Laboratories, Inc.. This Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Braintree Laboratories, Inc. |
| NON-PROPRIETARY NAME: | sodium sulfate, potassium sulfate, magnesium sulfate |
| SUBSTANCE NAME: | SODIUM SULFATE; POTASSIUM SULFATE; MAGNESIUM SULFATE, UNSPECIFIED FORM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE] |
| ROUTE: | ORAL |
| DOSAGE FORM: | SOLUTION, CONCENTRATE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2010-08-05 |
| END MARKETING DATE: | 0000-00-00 |
SUPREP Bowel Prep HUMAN PRESCRIPTION DRUG Details:
| Item Description | SUPREP Bowel Prep from Braintree Laboratories, Inc. |
| LABELER NAME: | Braintree Laboratories, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 17.5; 3.13; 1.6(g/mL; g/mL; g/mL) |
| START MARKETING DATE: | 2010-08-05 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 52268-012_45bc0b79-de6f-4a83-850d-55116da0c05b |
| PRODUCT NDC: | 52268-012 |
| APPLICATION NUMBER: | NDA022372 |
Other SODIUM SULFATE; POTASSIUM SULFATE; MAGNESIUM SULFATE, UNSPECIFIED FORM Pharmaceutical Manufacturers / Labelers:
